Recruiting pBI-11 & TA-HPV (With Pembrolizumab as Treatment for Patients w/Advanced, PD-L1 CPS≥1, hrHPV+ Oropharyngeal Cancer NCT05799144 Conditions Head and Neck Neoplasms, Metastatic Oropharyngeal Carcinoma, Neoplasms, +8 more Locations University of Alabama Birmingham — Birmingham, Alabama, United States Vanderbilt University/Ingram Cancer Center — Nashville, Tennessee, United States View Trial Details
Recruiting Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population NCT06997068 Conditions Carcinoma, Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Head and Neck Cancer, +34 more Locations Mayo Clinic in Rochester — Rochester, Minnesota, United States View Trial Details
